Author

C. W. Tan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 4 Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

L.-F. Wang· 2 shared A. L. St. John· 1 shared A. ONeill· 1 shared A. P. S. Rathore· 1 shared A. Takanashi· 1 shared A. Y.-Y. Yeoh· 1 shared B. Y. L. Chua· 1 shared C. K. Mantri· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L.-F. Wang

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting

H. A. Al-Wassiti, S. A. Fabb, S. L. Grimley, R. Kochappan, J. K. Ho, C. Y. Wong, C. W. Tan, T. J. Payne, A. Takanashi, H. Sicilia, S. L. Y. Teo, J. L. McAuley, P. Ellenberg, J. P. Cooney, K. C. Davidson, , C. W. Pouton

bioRxiv · Oct 4, 2023Immunology

Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses

N. Y. Z. Cheang, P. S. Tan, K. Purushotorman, W. C. Yap, B. Y. L. Chua, K. S. Tan, K. M. Tullett, A. Y.-Y. Yeoh, C. Q. H. Tan, X. Qian, D. J. W. Tay, I. Caminschi, Y. J. Tan, P. A. MacAry, C. W. Tan, , S. Alonso

This study evaluates a SARS-CoV-2 vaccine candidate that targets dendritic cells, showing durable systemic and mucosal immune responses against multiple variants.

bioRxiv · Feb 21, 2023 · PreprintImmunology

Mucosal vaccination for SARS-CoV-2 elicits superior systemic T central memory function and cross-neutralizing antibodies against variants of concern

A. ONeill, M. P. Kala, C. W. Tan, W. A. A. Saron, C. K. Mantri, A. P. S. Rathore, L.-F. Wang, A. L. St. John

This study shows that intranasal vaccination with SARS-CoV-2 S-RBD and mucosal adjuvant M7 enhances T central memory cells and cross-neutralizing antibodies against variants of concern compared to subcutaneous vaccination.

bioRxiv · Sep 9, 2022 · PreprintImmunology

Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive EV-A71 virulence in mice

H. K. Tee, C. W. Tan, T. Yogarajah, M. H. P. Lee, H. J. Chai, N. A. Hanapi, S. R. Yusof, K. C. Ong, V. S. Lee, I.-C. Sam, Y. F. Chan

This study shows that electrostatic interactions at the five-fold axis of EV-A71 influence heparin-binding and drive virulence in mice by altering viremia and neuroinvasion.

bioRxiv · May 23, 2019Microbiology